List of Studies

Back
Study IDStudy TitleLanguage Clinical Study Result Plain Language Summary
9853-CL-0101A Phase 1, Multicenter, Open-Label, Dose Escalation Study of ASP9853 in Combination with Either Docetaxel or Paclitaxel in Subjects with Advanced Non-hematologic Malignancies English


English


QUICK SEARCH

USEFUL LINKS